Skip to main content

Advertisement

SpringerLink
Log in

Sentinel lymph node biopsy progress in surgical treatment of cancer

  • New Surgical Horizons
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Forty-three years after the first description of the sentinel lymph node technique in malignant tumours of the parotid by Gould, sentinel lymph node biopsy (SNLB) has become a precious tool in the treatment of solid tumours.

Methods

In the following review we give a synopsis of the fundamentals of the sentinel lymph node concept and then proceed to an overview of recent advances of SNLB in gastrointestinal cancers.

Results

In some tumour entities, SNLB has been shown to reflect reliably the lymph node status of the tumour-draining lymph node basin. In melanoma and breast cancer, it became a widely accepted element of the routine surgical management of these malignant diseases. In gastrointestinal tumours, the technique is currently under intense investigation. First reports on its application in other solid tumours, such as non-small cell lung cancer, thyroid carcinoma, oropharyngeal carcinoma, vulvar carcinoma, and Merckel cell carcinoma of the skin, were published more recently.

Conclusion

SNLB has become an important component of diagnosis and treatment of solid tumours. A growing number of publications on SNLB in gastrointestinal cancer documents the interest of many investigators in the application of this technique in this tumour entity. As long as imaging techniques like 18FDG PET or other molecular imaging techniques are limited by their spatial resolution, SNLB remains the technique of choice for lympho-nodal staging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sappey M (1834) Injection, préparation et conservation des vaisseaux lymphatiques. Thése pour le Doctorat en Médecine, Faculté de Médecine, Paris

  2. Weinberg J, Greaney EM (1950) Identification of regional lymph nodes by means of a vital staining dye during surgery of gastric cancer. Surg Gynecol Obstet 90:561–567

    Google Scholar 

  3. Gould E, Winship T, Philbin P, Kerr H (1960) Observations on a sentinel node in cancer of the parotid. Cancer 13:77–78

    CAS  PubMed  Google Scholar 

  4. Cox KR, Hare WS, Bruce PT (1966) Lymphography in melanoma. Correlation of radiology with pathology. Cancer 19:637–647

    CAS  PubMed  Google Scholar 

  5. Abbes M (1967) Experience with lymphangiography in the surgical management of breast cancer. Int Surg 47:243–245

    CAS  PubMed  Google Scholar 

  6. Cabanas RM (1977) An approach for the treatment of penile carcinoma. Cancer 39:456–466

    PubMed  Google Scholar 

  7. Holmes EC, Moseley HS, Morton DL, Clark W, Robinson D, Urist MM (1977) A rational approach to the surgical management of melanoma. Ann Surg 186:481–490

    CAS  PubMed  Google Scholar 

  8. Robinson DS, Sample WF, Fee HJ, Holmes C, Morton DL (1977) Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal gold scanning. Surg Forum 28:147–148

    CAS  PubMed  Google Scholar 

  9. Wong JH, Cagle LA, Morton DL (1991) Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 214:637–641

    CAS  PubMed  Google Scholar 

  10. Morton D, Cagle L, Wong J, Economou J, Foshag L, Wen D (1990) Intraoperative lymphatic mapping and selective lymphadenectomy: technical details of a new procedure for clinical stage I melanoma (Abstract). Annual meeting of the Society for Surgical Oncology, Washington, DC

  11. Koch WM, Choti MA, Civelek AC, Eisele DW, Saunders JR (1998) Gamma probe-directed biopsy of the sentinel node in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 124:455–459

    CAS  PubMed  Google Scholar 

  12. Kelemen PR, Van Herle AJ, Giuliano AE (1998) Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 133:288–292

    CAS  PubMed  Google Scholar 

  13. Levenback C, Burke TW, Morris M, Malpica A, Lucas KR, Gershenson DM (1995) Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 59:216–220

    Article  CAS  PubMed  Google Scholar 

  14. Decesare SL, Fiorica JV, Roberts WS, Reintgen D, Arango H, Hoffman MS, Puleo C, Cavanagh D (1997) A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol 66:425–428

    CAS  PubMed  Google Scholar 

  15. Wasserberg N, Schachter J, Fenig E, Feinmesser M, Gutman H (2000) Applicability of the sentinel node technique to Merkel cell carcinoma. Dermatol Surg 26:138–141

    Article  CAS  PubMed  Google Scholar 

  16. Melfi FM, Chella A, Menconi GF, Givigliano F, Boni G, Mariani G, Sbragia P, Angeletti CA (2003) Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancer. Eur J Cardiothorac Surg 23:214–220

    Article  PubMed  Google Scholar 

  17. Vogt H, Wawroschek F, Wengenmair H, Wagner T, Kopp J, Dorn R, Grober S, Heidenreich P (2002) Sentinel lymph node diagnosis in prostatic carcinoma I: method and clinical evaluation. Nuklearmedizin 41:95–101

    CAS  PubMed  Google Scholar 

  18. Sasako M, McCulloch P, Kinoshita T, Maruyama K (1995) New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82:346–351

    CAS  PubMed  Google Scholar 

  19. Kosaka T, Ueshige N, Sugaya J, Nakano Y, Akiyama T, Tomita F, Saito H, Kita I, Takashima S (1999) Lymphatic routes of the stomach demonstrated by gastric carcinomas with solitary lymph node metastasis. Surg Today 29:695–700

    Article  CAS  PubMed  Google Scholar 

  20. Kampschoer GH, Maruyama K, van de Velde CJ, Sasako M, Kinoshita T, Okabayashi K (1989) Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br J Surg 76:905–908

    CAS  PubMed  Google Scholar 

  21. Fass J, Hungs M, Reineke T, Nachtkamp J, Schumpelick V (1994) Prognostic improvement by R1 and R2 lymphadenectomy in stomach carcinoma. Chirurg 65:867–872

    CAS  PubMed  Google Scholar 

  22. Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 80:1015–1018

    CAS  PubMed  Google Scholar 

  23. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ (1999) Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 340:908–914

    Article  CAS  PubMed  Google Scholar 

  24. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79:1522–1530

    Article  CAS  PubMed  Google Scholar 

  25. Hiratsuka M, Miyashiro I, Ishikawa O, Furukawa H, Motomura K, Ohigashi H, Kameyama M, Sasaki Y, Kabuto T, Ishiguro S, Imaoka S, Koyama H (2001) Application of sentinel node biopsy to gastric cancer surgery. Surgery 129:335–340

    Google Scholar 

  26. Ichikura T, Morita D, Uchida T, Okura E, Majima T, Ogawa T, Mochizuki H (2002) Sentinel node concept in gastric carcinoma. World J Surg 26:318–322

    Article  PubMed  Google Scholar 

  27. Palaia R, Cremona F, Delrio P, Izzo F, Ruffolo F, Parisi V (1999) Sentinel node biopsy in gastric cancer. J Chemother 11:230–231

    CAS  PubMed  Google Scholar 

  28. Kitagawa Y, Fujii H, Mukai M, Kubota T, Otani Y, Kitajima M (2002) Radio-guided sentinel node detection for gastric cancer. Br J Surg 89:604–608

    CAS  PubMed  Google Scholar 

  29. Miwa K, Kinami S, Taniguchi K, Fushida S, Fujimura T, Nonomura A (2003) Mapping sentinel nodes in patients with early-stage gastric carcinoma. Br J Surg 90:178–182

    Article  CAS  PubMed  Google Scholar 

  30. Tonouchi H, Mohri Y, Tanaka K, Konishi N, Ohmori Y, Kobayashi M, Watanabe Y, Matsumura K, Takeda K, Kusunoki M (2003) Lymphatic mapping and sentinel node biopsy during laparoscopic gastrectomy for early cancer. Dig Surg 20:421–427

    Article  PubMed  Google Scholar 

  31. Shiozawa M, Kawamoto M, Ishiwa N, Rino Y, Takanashi Y, Nakatani Y, Inayama Y, Imada T (2003) Clinical usefulness of intraoperative sentinel-node biopsy in gastric cancer. Hepatogastroenterology 50:1187–1189

    PubMed  Google Scholar 

  32. Kitagawa Y, Ohgami M, Fujii H, Mukai M, Kubota T, Ando N, Watanabe M, Otani Y, Ozawa S, Hasegawa H, Furukawa T, Matsuda J, Kumai K, Ikeda T, Kubo A, Kitajima M (2001) Laparoscopic detection of sentinel lymph nodes in gastrointestinal cancer: a novel and minimally invasive approach. Ann Surg Oncol 8:86S–89S

    CAS  PubMed  Google Scholar 

  33. Kato H, Miyazaki T, Nakajima M, Takita J, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Asao T, Kuwano H, Oriuchi N, Endo K (2003) Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma. Cancer 98:932–939

    Article  PubMed  Google Scholar 

  34. Yasuda S, Shimada H, Chino O, Tanaka H, Kenmochi T, Takechi M, Nabeshima K, Okamoto Y, Kato Y, Kijima H, Suzuki Y, Ogoshi K, Tajima, T, Makuuchi H (2003) Sentinel lymph node detection with Tc-99m tin colloids in patients with esophagogastric cancer. Jpn J Clin Oncol 33:68–72

    Article  PubMed  Google Scholar 

  35. Feith M, Stein HJ, Siewert JR (2003) Pattern of lymphatic spread of Barrett’s cancer. World J Surg 27:1052–1057

    Article  PubMed  Google Scholar 

  36. investigators IB (1999) Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol 17:1356–1363

    PubMed  Google Scholar 

  37. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, et al (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352–358

    CAS  PubMed  Google Scholar 

  38. Daneker GW Jr, Ellis LM (1996) Colon cancer nodal metastasis: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5:173–189

    PubMed  Google Scholar 

  39. Cserni G, Vajda K, Tarjan M, Bori R, Svebis M, Baltas B (1999) Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathol Oncol Res 5:291–296

    Article  CAS  PubMed  Google Scholar 

  40. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ (1999) Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 86:482–486

    Article  CAS  PubMed  Google Scholar 

  41. Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK, Desai D, Kaushal S, Nagaraju M, Arora M, Singh T (2000) Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 7:120–124

    CAS  PubMed  Google Scholar 

  42. Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, Turner RR, Wang HJ, Morton DL, Hoon DS (2001) Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 19:1128–1136

    CAS  PubMed  Google Scholar 

  43. Saha S, Bilchik A, Wiese D, Espinosa M, Badin J, Ganatra BK, Desai D, Kaushal S, Singh T, Arora M (2001) Ultrastaging of colorectal cancer by sentinel lymph node mapping technique—a multicenter trial. Ann Surg Oncol 8:94S–98S

    CAS  PubMed  Google Scholar 

  44. Bilchik AJ, Nora D, Tollenaar RA, van de Velde CJ, Wood T, Turner R, Morton DL, Hoon DS (2002) Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer 38:977–985

    Article  CAS  PubMed  Google Scholar 

  45. Paramo JC, Summerall J, Poppiti R, Mesko TW (2002) Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol 9:550–554

    Article  PubMed  Google Scholar 

  46. Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W Jr, Foshag LJ, Bilchik AJ (2001) Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 8:150–157

    Article  CAS  PubMed  Google Scholar 

  47. Merrie AE, van Rij AM, Phillips LV, Rossaak JI, Yun, K, McCall JL (2001) Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 44:410–417

    CAS  PubMed  Google Scholar 

  48. Trocha SD, Nora DT, Saha SS, Morton DL, Wiese D, Bilchik AJ (2003) Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer. J Gastrointest Surg 7:340–345; discussion 345–346

    Article  PubMed  Google Scholar 

  49. Broderick-Villa G, Ko A, TX OC, Guenther JM, Danial, T, DiFronzo LA (2002) Does tumor burden limit the accuracy of lymphatic mapping and sentinel lymph node biopsy in colorectal cancer? Cancer J 8:445–450

    PubMed  Google Scholar 

  50. Fitzgerald TL, Khalifa MA, Al Zahrani M, Law CH, Smith AJ (2002) Ex vivo sentinel lymph node biopsy in colorectal cancer: a feasibility study. J Surg Oncol 80:27–32; discussion 33

    Article  CAS  PubMed  Google Scholar 

  51. Tsioulias GJ, Wood TF, Morton DL, Bilchik AJ (2000) Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms. Arch Surg 135:926–932

    CAS  PubMed  Google Scholar 

  52. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73:563–569

    CAS  PubMed  Google Scholar 

  53. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, Tollenaar RA (1998) Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339:223–228

    CAS  PubMed  Google Scholar 

  54. Clarke G, Ryan E, JC, OK, Crowe J, MacMathuna P (2000) The detection of cytokeratins in lymph nodes of Duke’s B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol 12:549–552

    CAS  PubMed  Google Scholar 

  55. Rosenberg R, Hoos A, Mueller J, Baier P, Stricker D, Werner M, Nekarda H Siewert JR (2002) Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 20:1049–1055

    Article  PubMed  Google Scholar 

  56. Isaka N, Nozue M, Doy M, Fukao K (1999) Prognostic significance of perirectal lymph node micrometastases in Dukes’ B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 5:2065–2068

    CAS  PubMed  Google Scholar 

  57. Haboubi NY, Abdalla SA, Amini S, Clark P, Dougal M, Dube A, Schofield P (1998) The novel combination of fat clearance and immunohistochemistry improves prediction of the outcome of patients with colorectal carcinomas: a preliminary study. Int J Colorectal Dis 13:99–102

    Article  CAS  PubMed  Google Scholar 

  58. Cutait R, Alves VA, Lopes LC, Cutait DE, Borges JL, Singer J, da Silva JH, Goffi FS (1991) Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34:917–920

    CAS  PubMed  Google Scholar 

  59. Jeffers MD, GM, OD, Mulcahy H, Stagg M, DP, OD, Toner M (1994) The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 172:183–187

    CAS  PubMed  Google Scholar 

  60. Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L (1996) Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes’ B colorectal carcinoma: an immunohistochemical study. Eur J Surg 162:637–642

    CAS  PubMed  Google Scholar 

  61. Broll R, Schauer V, Schimmelpenning H, Strik M, Woltmann A, Best R, Bruch HP, Duchrow M (1997) Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study. Dis Colon Rectum 40:1465–1471

    CAS  PubMed  Google Scholar 

  62. Noura S, Yamamoto H, Miyake Y, Kim B, Takayama O, Seshimo I, Ikenaga M, Ikeda M, Sekimoto M, Matsuura N, Monden M (2002) Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer. Clin Cancer Res 8:759–767

    PubMed  Google Scholar 

  63. Choi HJ, Choi YY, Hong SH (2002) Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma. Dis Colon Rectum 45:750–755

    PubMed  Google Scholar 

  64. Nakanishi Y, Ochiai A, Yamauchi Y, Moriya Y, Yoshimura K, Hirohashi S (1999) Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study. Oncology 57:276–280

    Article  CAS  PubMed  Google Scholar 

  65. Oberg A, Stenling R, Tavelin B, Lindmark G (1998) Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum 41:1244–1249

    CAS  PubMed  Google Scholar 

  66. Wood TF, Spirt M, Rangel D, Shen P, Tsioulias GJ, Morton DL, Bilchik AJ (2001) Lymphatic mapping improves staging during laparoscopic colectomy for cancer. Surg Endosc 15:715–719

    Article  CAS  PubMed  Google Scholar 

  67. Wong JH, Steineman S, Calderia C, Bowles J, Namiki T (2001) Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg 233:515–521

    Article  CAS  PubMed  Google Scholar 

  68. Ryan DP, Compton CC, Mayer RJ (2000) Carcinoma of the anal canal. N Engl J Med 342:792–800

    Article  CAS  PubMed  Google Scholar 

  69. Smith AJ, Whelan P, Cummings BJ, Stern HS (2001) Management of persistent or locally recurrent epidermoid cancer of the anal canal with abdominoperineal resection. Acta Oncol 40:34–36

    Article  CAS  PubMed  Google Scholar 

  70. Gerard JP, Chapet O, Samiei F, Morignat E, Isaac S, Paulin C, Romestaing P, Favrel V, Mornex F, Bobin JY (2001) Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 92:77–84

    Article  CAS  PubMed  Google Scholar 

  71. Boman BM, Moertel CG, MJ, OC, Scott M, Weiland LH, Beart RW, Gunderson LL, Spencer RJ (1984) Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer 54:114–125

    CAS  PubMed  Google Scholar 

  72. Papillon J, Montbarbon JF (1987) Epidermoid carcinoma of the anal canal. A series of 276 cases. Dis Colon Rectum 30:324–333

    CAS  PubMed  Google Scholar 

  73. Golden GT, Horsley JS III (1976) Surgical management of epidermoid carcinoma of the anus. Am J Surg 131:275–280

    CAS  PubMed  Google Scholar 

  74. Gordon PH (1990) Current status—perianal and anal canal neoplasms. Dis Colon Rectum 33:799–808

    CAS  PubMed  Google Scholar 

  75. Stearns MW Jr, Urmacher C, Sternberg SS, Woodruff J, Attiyeh F (1980) Cancer of the anal canal. Curr Probl Cancer 4:1–44

    Google Scholar 

  76. Pintor MP, Northover JM, Nicholls RJ (1989) Squamous cell carcinoma of the anus at one hospital from 1948 to 1984. Br J Surg 76:806–810

    CAS  PubMed  Google Scholar 

  77. Wade DS, Herrera L, Castillo NB, Petrelli NJ (1989) Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique. Surg Gynecol Obstet 169:238–242

    CAS  PubMed  Google Scholar 

  78. Clark J, Petrelli N, Herrera L, Mittelman A (1986) Epidermoid carcinoma of the anal canal. Cancer 57:400–406

    CAS  PubMed  Google Scholar 

  79. Perera D, Pathma-Nathan N, Rabbitt P, Hewett P, Rieger N (2003) Sentinel node biopsy for squamous-cell carcinoma of the anus and anal margin. Dis Colon Rectum 46:1027–1029; discussion 1030–1021

    CAS  PubMed  Google Scholar 

  80. Damin DC, Rosito MA, Gus P, Spiro BL, Amaral BB, Meurer L, Cartel A, Schwartsmann G (2003) Sentinel lymph node procedure in patients with epidermoid carcinoma of the anal canal: early experience. Dis Colon Rectum 46:1032–1037

    PubMed  Google Scholar 

  81. Ulmer C, Bembenek A, Gretschel S, Markwardt J, Koswig S, Slisow W, Schneider U, Schlag PM (2003) Sentinel node biopsy in anal cancer-a promising strategy to individualize therapy. Onkologie 26:456–460

    Article  CAS  PubMed  Google Scholar 

  82. Canavese G, Catturich A, Vecchio C, Tomei D, Gipponi M, Bruzzi P, Badellino F (1998) Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol 24:104–109

    CAS  PubMed  Google Scholar 

  83. Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK (1999) Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 17:2334–2340

    PubMed  Google Scholar 

  84. Shetty MR, Reiman HM Jr (1997) Tumor size and axillary metastasis, a correlative occurrence in 1244 cases of breast cancer between 1980 and 1995. Eur J Surg Oncol 23:139–141

    CAS  PubMed  Google Scholar 

  85. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, Robertson C, Sacchini V, Veronesi P, Orvieto E, De Cicco C, Intra M, Tosi G, Scarpa D (1999) Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91:368–373

    Article  CAS  PubMed  Google Scholar 

  86. Mariani G, Villa G, Gipponi M, Bianchi P, Buffoni F, Agnese G, Vecchio C, Tomei D, Carli F, Nicolo, G, Canavese G (2000) Mapping sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue-dye, and intraoperative gamma-probe. Cancer Biother Radiopharm 15:245–252

    Article  CAS  PubMed  Google Scholar 

  87. Giuliano AE, Jones RC, Brennan M, Statman R (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345–2350

    CAS  PubMed  Google Scholar 

  88. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P (1998) The sentinel node in breast cancer—a multicenter validation study. N Engl J Med 339:941–946

    CAS  PubMed  Google Scholar 

  89. Hill AD, Tran KN, Akhurst T, Yeung H, Yeh SD, Rosen PP, Borgen PI, Cody HSr (1999) Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 229:528–535

    CAS  PubMed  Google Scholar 

  90. McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, Vennekotter DJ, Turk PS, Tate PS, Sardi A, Cerrito PB, Edwards MJ (2000) Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18:2560–2566

    CAS  PubMed  Google Scholar 

  91. Bembenek A, Haensch W, Schneider U, Markwardt J, Schlag P (2000) 24. Deutscher Krebskongress. Presentation M (ed) Berlin

    Google Scholar 

  92. Bergkvist L, Frisell J, Liljegren G, Celebioglu F, Damm S, Thorn M (2001) Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 88:1644–1648

    Article  CAS  PubMed  Google Scholar 

  93. D’Eredita G, Mele M, Serio G, Giardina C, Natale T, Martellotta M, Ferrarese F (2001) Initial experience with sentinel lymph node mapping and biopsy in breast cancer. Preliminary results on 80 consecutive patients. J Exp Clin Cancer Res 20:469–472

    CAS  PubMed  Google Scholar 

  94. Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, Ng PC, Edwards MS, Halliday BE, Henry CA, Sommers LM, Carman CM, Molin MR, Yurko JE, Perry RR, Williams R (2001) Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233:51–59

    CAS  PubMed  Google Scholar 

  95. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553

    Article  PubMed  Google Scholar 

  96. Krag D, Ashikaga T (2003) The design of trials comparing sentinel-node surgery and axillary resection. N Engl J Med 349:603–605

    Article  PubMed  Google Scholar 

  97. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394–399; discussion 399–401

    CAS  PubMed  Google Scholar 

  98. Turner RR, Ollila DW, Krasne DL, Giuliano AE (1997) Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226:271–276; discussion 276–278

    Article  CAS  PubMed  Google Scholar 

  99. Weaver DL, Krag DN, Ashikaga T, Harlow SP, M, OC (2000) Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 88:1099–1107

    Article  CAS  PubMed  Google Scholar 

  100. Turner RR, Ollila DW, Stern S, Giuliano AE (1999) Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 23:263–267

    Article  CAS  PubMed  Google Scholar 

  101. Pendas S, Dauway E, Cox CE, Giuliano R, Ku NN, Schreiber RH, Reintgen DS (1999) Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 65:500–505; discussion 505–506

    CAS  PubMed  Google Scholar 

  102. Schreiber RH, Pendas S, Ku NN, Reintgen DS, Shons AR, Berman C, Boulware D, Cox CE (1999) Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol 6:95–101

    CAS  PubMed  Google Scholar 

  103. Dowlatshahi K, Fan M, Snider HC, HabibFA (1997) Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80:1188–1197

    Article  CAS  PubMed  Google Scholar 

  104. Sedmak DD, Meineke TA, Knechtges DS, Anderson J (1989) Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 2:516–520

    CAS  PubMed  Google Scholar 

  105. Hainsworth PJ, Tjandra JJ, Stillwell RG, Machet D, Henderson MA, Rennie GC, McKenzie IF, Bennett RC (1993) Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 80:459–463

    CAS  PubMed  Google Scholar 

  106. Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Gusterson B, Neville AM (1999) Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 354:896–900

    PubMed  Google Scholar 

  107. Hansen N, Grube B, Te W (2001) Clinical significance of axillary micrometastases in breast cancer: How small is too small? (Abstract 91) Proc Am Soc Clin Oncol 20:249

    Google Scholar 

  108. Cox CE, Nguyen K, Gray RJ, Salud C, Ku NN, Dupont E, Hutson L, Peltz E, Whitehead G, Reintgen D, Cantor A (2001) Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 67:513–519; discussion 519–521

    CAS  PubMed  Google Scholar 

  109. Solin LJ, Kurtz J, Fourquet A, Amalric R, Recht A, Bornstein BA, Kuske R, Taylor M, Barrett W, Fowble B, Haffty B, Schultz DJ, Yeh IT, McCormick B, McNeese M (1996) Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14:754–763

    CAS  PubMed  Google Scholar 

  110. Dowlatshahi K, Fan M, Bloom KJ, Spitz DJ, Patel S, Snider HC Jr (1999) Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer 86:990–996

    Article  CAS  PubMed  Google Scholar 

  111. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL (2002) Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628–3636

    Article  PubMed  Google Scholar 

  112. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R (1985) Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674–681

    CAS  PubMed  Google Scholar 

  113. Newman LA, Hunt KK, Buchholz T, Kuerer HM, Vlastos G, Mirza N, Ames FC, Ross MI, Singletary SE (2000) Presentation, management and outcome of axillary recurrence from breast cancer. Am J Surg 180:252–256

    Article  CAS  PubMed  Google Scholar 

  114. Veronesi U, Galimberti V, Zurrida S, Pigatto F, Veronesi P, Robertson C, Paganelli G, Sciascia V, Viale G (2001) Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 37:454–458

    CAS  PubMed  Google Scholar 

  115. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, Glass EC, Turner RR (2000) Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18:2553–2559

    CAS  PubMed  Google Scholar 

  116. Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A, Waynad W (2001) Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 77:165–170

    Article  CAS  PubMed  Google Scholar 

  117. Chung MA, Steinhoff MM, Cady B (2002) Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 184:310–314

    Article  PubMed  Google Scholar 

  118. Loza J, Colo F, Nadal J, Viniegra M, Chacon R (2002) Axillary recurrence after sentinel node biopsy for operable breast cancer. Eur J Surg Oncol 28:897–898

    Article  CAS  Google Scholar 

  119. Reitsamer R, Peintinger F, Prokop E, Menzel C, Cimpoca W, Rettenbacher L (2003) Sentinel lymph node biopsy alone without axillary lymph node dissection—follow-up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 29:221–223

    Article  CAS  PubMed  Google Scholar 

  120. Badgwell BD, Povoski SP, Abdessalam SF, Young DC, Farrar WB, Walker MJ, Yee LD, Zervos EE, Carson WEr, Burak WE Jr (2003) Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol 10:376–380

    Article  PubMed  Google Scholar 

  121. Takei H, Suemasu K, Kurosumi M, Uchida K, Igarashi K, Ninomiya J, Naganuma R, Kusawake T, Sugamata N, Matsumoto H, Higashi Y (2002) Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases. Breast Cancer 9:344–348

    PubMed  Google Scholar 

  122. Blanchard DK, Donohue JH, Reynolds C, Grant CS (2003) Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482–487; discussion 487–488

    Article  PubMed  Google Scholar 

  123. Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B, Kuerer HM, Singletary SE, Babiera G, Meric F, Akins JS, Neely J, Ross MI (2003) Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10:248–254

    Article  PubMed  Google Scholar 

  124. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik, A, Giuliano AE (1999) Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229:536–541

    Article  CAS  PubMed  Google Scholar 

  125. Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE (1999) Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol 6:756–761

    CAS  PubMed  Google Scholar 

  126. Sachdev U, Murphy K, Derzie A, Jaffer S, Bleiweiss IJ, Brower S (2002) Predictors of nonsentinel lymph node metastasis in breast cancer patients. Am J Surg 183:213–217

    Article  PubMed  Google Scholar 

  127. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, Orel SG, Keeney GL, Lawton TJ, Czerniecki BJ (1999) Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17:1720–1726

    CAS  PubMed  Google Scholar 

  128. Travagli JP, Atallah D, Mathieu MC, Rochard F, Camatte S, Lumbroso J, Garbay JR, Rouzier R (2003) Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. Eur J Surg Oncol 29:403–406

    Article  PubMed  Google Scholar 

  129. Guenther JM, Hansen NM, DiFronzo LA, Giuliano AE, Collins JC, Grube BL, TX OC (2003) Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 138:52–56

    PubMed  Google Scholar 

  130. Fant JS, Grant MD, Knox SM, Livingston SA, Ridl K, Jones RC, Kuhn JA (2003) Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 10:126–130

    Article  PubMed  Google Scholar 

  131. Cody HSr, Urban JA (1995) Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 2:32–37

    PubMed  Google Scholar 

  132. Veronesi U, Cascinelli N, Bufalino R, Morabito A, Greco M, Galluzzo D, Delle Donne V, De Lellis R, Piotti P, Sacchini V et al (1983) Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 198:681–684

    CAS  PubMed  Google Scholar 

  133. Byrd DR, Dunnwald LK, Mankoff DA, Anderson BO, Moe RE, Yeung RS, Schubert EK, Eary JF (2001) Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol 8:234–240

    CAS  PubMed  Google Scholar 

  134. Czerniecki BJ, Bedrosian I, Faries M, Alavi A (2001) Revolutionary impact of lymphoscintigraphy and intraoperative sentinel node mapping in the clinical practice of oncology. Semin Nucl Med 31:158–164

    PubMed  Google Scholar 

  135. van der Ent FW, Kengen RA, van der Pol HA, Povel JA, Stroeken HJ, Hoofwijk AG (2001) Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 234:79–84

    Article  PubMed  Google Scholar 

  136. Galimberti V, Veronesi P, Arnone P, De Cicco C, Renne G, Intra M, Zurrida S, Sacchini V, Gennari R, Vento A, Luini A, Veronesi U (2002) Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol 9:924–928

    PubMed  Google Scholar 

  137. Estourgie SH, Tanis PJ, Nieweg OE, Valdes Olmos RA, Rutgers EJ, Kroon BB (2003) Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol 10:935–941

    Article  PubMed  Google Scholar 

  138. Ogawa Y, Ishikawa T, Sawada T, Chung SH, Osaka H, Takashima T, Onoda N, Kato Y, Ochi, H, Hirakawa K (2003) Thoracoscopic internal mammary sentinel node biopsy for breast cancer. Surg Endosc 17:315–319

    Article  CAS  PubMed  Google Scholar 

  139. Ververs JM, Roumen RM, Vingerhoets AJ, Vreugdenhil G, Coebergh JW, Crommelin MA, Luiten EJ, Repelaer van Driel OJ, Schijven M, Wissing JC, Voogd AC (2001) Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 37:991–999

    Article  CAS  PubMed  Google Scholar 

  140. Petrek JA, Senie RT, Peters, M, Rosen PP (2001) Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 92:1368–1377

    Article  CAS  PubMed  Google Scholar 

  141. Schrenk P, Rieger R, Shamiyeh A, Wayand W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608–614

    Article  CAS  PubMed  Google Scholar 

  142. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC (2002) Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183:23–27

    PubMed  Google Scholar 

  143. Schijven MP, Vingerhoets AJ, Rutten HJ, Nieuwenhuijzen GA, Roumen RM, van Bussel ME, Voogd AC (2003) Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29:341–350

    Article  CAS  PubMed  Google Scholar 

  144. Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G (2002) Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73:31–36

    PubMed  Google Scholar 

  145. Sener SF, Winchester DJ, Martz CH, Feldman JL, Cavanaugh JA, Winchester DP, Weigel B, Bonnefoi K, Kirby K, Morehead C (2001) Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92:748–752

    Article  CAS  PubMed  Google Scholar 

  146. Rietman JS, Dijkstra PU, Geertzen JH, Baas P, De Vries J, Dolsma W, Groothoff JW, Eisma WH, Hoekstra HJ (2003) Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma. Cancer 98:690–696

    Article  PubMed  Google Scholar 

  147. Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB Jr, Fisher ER, Wickerham DL, Wolmark N, DeCillis A, Hoehn JL, Lees AW, Dimitrov NV (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483–2493

    CAS  PubMed  Google Scholar 

  148. Mamounas EP, Fisher B (2000) Preoperative chemotherapy for operable breast cancer. Cancer Treat Res 103:137–155

    CAS  PubMed  Google Scholar 

  149. Balch GC, Mithani SK, Richards KR, Beauchamp RD, Kelley MC (2003) Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol 10:616–621

    Article  PubMed  Google Scholar 

  150. Schwartz GF, Meltzer AJ (2003) Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 9:374–379

    Article  PubMed  Google Scholar 

  151. Piato JR, Barros AC, Pincerato KM, Sampaio AP, Pinotti JA (2003) Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Oncol 29:118–120

    Article  PubMed  Google Scholar 

  152. Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA (2000) Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol 24:1266–1272

    Article  CAS  PubMed  Google Scholar 

  153. Breslin TM, Cohen L, Sahin A, Fleming JB, Kuerer HM, Newman LA, Delpassand ES, House R, Ames FC, Feig BW, Ross MI, Singletary SE, Buzdar AU, Hortobagyi GN, Hunt KK (2000) Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 18:3480–3486

    CAS  PubMed  Google Scholar 

  154. Nason KS, Anderson BO, Byrd DR, Dunnwald LK, Eary JF, Mankoff DA, Livingston R, Schmidt RA, Jewell KD, Yeung RS, Moe RE (2000) Increased false-negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 89:2187–2194

    CAS  PubMed  Google Scholar 

  155. Fernandez A, Cortes M, Benito E, Azpeitia D, Prieto L, Moreno A, Ricart Y, Mora J, Escobedo A, Martin Comin J (2001) Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun 22:361–366

    Article  CAS  PubMed  Google Scholar 

  156. Tafra L, Verbanac KM, Lannin DR (2001) Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg 182:312–315

    Article  CAS  PubMed  Google Scholar 

  157. Haid A, Tausch C, Lang A, Lutz J, Fritzsche H, Peschina W, Breitfellner G, Sega W, Aufschnaiter M, Sturn H, Zimmermann G (2001) Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 92:1080–1084

    Article  CAS  PubMed  Google Scholar 

  158. Brady EW (2002) Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J 8:97–100

    Article  PubMed  Google Scholar 

  159. Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN (2002) Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9:235–242

    Article  PubMed  Google Scholar 

  160. Julian TB, Dusi D, Wolmark N (2002) Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 184:315–317

    Article  PubMed  Google Scholar 

  161. Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF (2003) The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer 98:2105–2113

    Article  PubMed  Google Scholar 

  162. Silverstein MJ, Rosser RJ, Gierson ED, Waisman JR, Gamagami P, Hoffman RS, Fingerhut AG, Lewinsky BS, Colburn W, Handel N (1987) Axillary lymph node dissection for intraductal breast carcinoma—is it indicated? Cancer 59:1819–1824

    CAS  PubMed  Google Scholar 

  163. Wong JH, Kopald KH, Morton DL (1990) The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 125:1298–1301; discussion 1301–1292

    CAS  PubMed  Google Scholar 

  164. Silverstein MJ, Gierson ED, Colburn WJ, Rosser RJ, Waisman JR, Gamagami P (1991) Axillary lymphadenectomy for intraductal carcinoma of the breast. Surg Gynecol Obstet 172:211–214

    CAS  PubMed  Google Scholar 

  165. Solin LJ, Fowble BL, Yeh IT, Kowalyshyn MJ, Schultz DJ, Weiss MC, Goodman RL (1992) Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 23:961–968

    CAS  PubMed  Google Scholar 

  166. Silver SA, Tavassoli FA (1998) Mammary ductal carcinoma in situ with microinvasion. Cancer 82:2382–2390

    Article  CAS  PubMed  Google Scholar 

  167. Klauber-DeMore N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P, Heerdt A, Montgomery L, Paglia M, Petrek JA, Cody HS, Van Zee KJ (2000) Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in situ and ductal carcinoma-in situ with microinvasion? Ann Surg Oncol 7:636–642

    CAS  PubMed  Google Scholar 

  168. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS (2000) Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 7:15–20

    CAS  PubMed  Google Scholar 

  169. Intra M, Veronesi P, Mazzarol G, Galimberti V, Luini A, Sacchini V, Trifiro G, Gentilini O, Pruneri G, Naninato P, Torres F, Paganelli G, Viale G, Veronesi U (2003) Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138:309–313

    Article  PubMed  Google Scholar 

  170. Intra M, Zurrida S, Maffini F, Sonzogni A, Trifiro G, Gennari R, Arnone P, Bassani G, Opazo A, Paganelli G, Viale G, Veronesi U (2003) Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol 10:1160–1165

    Article  PubMed  Google Scholar 

  171. Youngson BJ, Cranor M, Rosen PP (1994) Epithelial displacement in surgical breast specimens following needling procedures. Am J Surg Pathol 18:896–903

    CAS  PubMed  Google Scholar 

  172. Tamhane R, Dahlstrom JE, McCallum DD, Buckingham JM (2002) The clinical significance of cytokeratin-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma-in-situ. Ann Surg Oncol 9:999–1003

    Article  PubMed  Google Scholar 

  173. Drepper H, Kohler CO, Bastian B, Breuninger H, Brocker EB, Gohl J, Groth W, Hermanek P, Hohenberger W, Lippold, A, et al (1993) Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients. Cancer 72:741–749

    CAS  PubMed  Google Scholar 

  174. McCarthy WH, Shaw HM, Milton GW (1985) Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma. Surg Gynecol Obstet 161:575–580

    CAS  PubMed  Google Scholar 

  175. Rompel R, Garbe C, Buttner P, Teichelmann K, Petres J (1995) Elective lymph node dissection in primary malignant melanoma: a matched-pair analysis. Melanoma Res 5:189–194

    CAS  PubMed  Google Scholar 

  176. Wanebo HJ, Woodruff J, Fortner JG (1975) Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer 35:666–676

    CAS  PubMed  Google Scholar 

  177. Veronesi U, Adamus J, Bandiera DC, Brennhovd O, Caceres E, Cascinelli N, Claudio F, Ikonopisov RL, Javorski VV, Kirov S, Kulakowski A, Lacour J, Lejeune F, Mechl Z, Morabito A, Rode I, Sergeev S, van Slooten E, Szczygiel K, Trapeznikov NN, Wagner RI (1982) Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49:2420–2430

    CAS  PubMed  Google Scholar 

  178. Balch CM, Soong SJ, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ, Temple WJ, Ross MI, Jewell WR, Mihm MC, Barnhill RL, Wanebo HJ (1996) Efficacy of an elective regional lymph node dissection of 1–4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224:255–263; discussion 263–256

    Article  CAS  PubMed  Google Scholar 

  179. Sim FH, Taylor WF, Pritchard DJ, Soule EH (1986) Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 61:697–705

    CAS  PubMed  Google Scholar 

  180. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F (1998) Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial. WHO Melanoma Programme. Lancet 351:793–796

    CAS  PubMed  Google Scholar 

  181. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399

    PubMed  Google Scholar 

  182. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, Heller R, Ross M, Lyman G et al (1994) The orderly progression of melanoma nodal metastases. Ann Surg 220:759–767

    CAS  Google Scholar 

  183. Wrightson WR, Wong SL, Edwards MJ, Chao C, Reintgen DS, Ross MI, Noyes RD, Viar V, Cerrito PB, McMasters KM (2003) Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 10:676–680

    Article  PubMed  Google Scholar 

  184. Leong SP, Steinmetz I, HabibFA, McMillan A, Gans JZ, Allen RE Jr, Morita ET, el-Kadi M, Epstein HD, Kashani-Sabet, M, Sagebiel RW (1997) Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 132:666–672; discussion 673

    CAS  PubMed  Google Scholar 

  185. Joseph E, Brobeil A, Glass F, Glass J, Messina J, DeConti R, Cruse CW, Rapaport DP, Berman C, Fenske, N, Reintgen DS (1998) Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol 5:119–125

    CAS  PubMed  Google Scholar 

  186. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, Lee JJ, Balch CM, Reintgen DS, Ross MI (1999) Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17:976–983

    CAS  PubMed  Google Scholar 

  187. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, Roses DF, Karakousis CP, Mozzillo N, Reintgen D, Wang HJ, Glass EC, Cochran AJ (1999) Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 230:453–463; discussion 463–455

    CAS  PubMed  Google Scholar 

  188. Gennari R, Bartolomei M, Testori A, Zurrida S, Stoldt HS, Audisio RA, Geraghty JG, Paganelli G, Veronesi U (2000) Sentinel node localization in primary melanoma: preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance. Surgery 127:19–25

    Article  CAS  PubMed  Google Scholar 

  189. Tremblay F, Louffi A, Shibata H, Meterissian S (2001) Sentinel lymph-node biopsy for melanoma of the trunk and extremities: the McGill experience. Can J Surg 44:428–431

    CAS  PubMed  Google Scholar 

  190. Jansen L, Koops HS, Nieweg OE, Doting MH, Kapteijn BA, Balm AJ, Vermey A, Plukker JT, Hoefnagel CA, Piers DA, Kroon BB (2000) Sentinel node biopsy for melanoma in the head and neck region. Head Neck 22:27–33

    Article  CAS  PubMed  Google Scholar 

  191. Thompson JF, McCarthy WH, Bosch CM, CJ, OB, Quinn MJ, Paramaesvaran S, Crotty K, McCarthy SW, Uren RF, Howman-Giles R (1995) Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 5:255–260

    CAS  PubMed  Google Scholar 

  192. Kapteijn BA, Nieweg OE, Liem I, Mooi WJ, Balm AJ, Muller SH, Peterse JL, Valdes Olmos RA, Hoefnagel CA, Kroon BB (1997) Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 4:156–160

    CAS  PubMed  Google Scholar 

  193. Gershenwald JE, Tseng CH, Thompson W, Mansfield PF, Lee JE, Bouvet M, Lee JJ, Ross MI (1998) Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. Surgery 124:203–210

    Article  CAS  PubMed  Google Scholar 

  194. Clary BM, Brady MS, Lewis JJ, Coit DG (2001) Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 233:250–258

    Article  CAS  PubMed  Google Scholar 

  195. Roozendaal GK, de Vries JD, van Poll D, Jansen L, Schraffordt Koops H, Nieweg OE, Kroon BB (2001) Sentinel nodes outside lymph node basins in patients with melanoma. Br J Surg 88:305–308

    Article  CAS  PubMed  Google Scholar 

  196. Doting MH, Hoekstra HJ, Plukker JT, Piers DA, Jager PL, Tiebosch AT, Vermey A, Schraffordt Koops H (2002) Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol 28:673–678

    Article  CAS  PubMed  Google Scholar 

  197. Li LX, Scolyer RA, Ka VS, McKinnon JG, Shaw HM, McCarthy SW, Thompson JF (2003) Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol 27:1197–1202

    PubMed  Google Scholar 

  198. Wagner JD, Ranieri J, Evdokimow DZ, Logan T, Chuang TY, Johnson CS, Jung SH, Wenck S, Coleman J Jr (2003) Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Plast Reconstr Surg 112:486–497

    Article  PubMed  Google Scholar 

  199. Vuylsteke RJ, van Leeuwen PA, Statius Muller MG, Gietema HA, Kragt DR, Meijer S (2003) Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol 21:1057–1065

    Article  CAS  PubMed  Google Scholar 

  200. Goydos JS, Patel KN, Shih WJ, Lu SE, Yudd AP, Kempf JS, Bancila E, Germino FJ (2003) Patterns of recurrence in patients with melanoma and histologically negative but RT-PCR-positive sentinel lymph nodes. J Am Coll Surg 196:196–204; discussion 204–195

    Article  PubMed  Google Scholar 

  201. Estourgie SH, Nieweg OE, Valdes Olmos RA, Hoefnagel CA, Kroon BB (2003) Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 10:681–688

    Article  PubMed  Google Scholar 

  202. Clary BM, Mann B, Brady MS, Lewis JJ, Coit DG (2001) Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol 8:328–337

    Article  CAS  PubMed  Google Scholar 

  203. Essner R, Conforti A, Kelley MC, Wanek L, Stern S, Glass E, Morton DL (1999) Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 6:442–449

    CAS  PubMed  Google Scholar 

  204. Gadd MA, Cosimi AB, Yu J, Duncan LM, Yu L, Flotte TJ, Souba WW, Ott MJ, Wong LS, Sober AJ, Mihm MC, Haluska FG, Tanabe KK (1999) Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 134:381–387

    Article  CAS  PubMed  Google Scholar 

  205. Gershenwald JE, Colome MI, Lee JE, Mansfield PF, Tseng C, Lee JJ, Balch CM, Ross MI (1998) Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16:2253–2260

    CAS  PubMed  Google Scholar 

  206. Morton DL, Hoon DS, Cochran AJ, Turner RR, Essner R, Takeuchi H, Wanek LA, Glass E, Foshag LJ, Hsueh EC, Bilchik AJ, Elashoff, D, Elashoff R (2003) Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 238:538–549; discussion 549–550

    Article  PubMed  Google Scholar 

  207. Wagner JD, Corbett L, Park HM, Davidson D, Coleman JJ, Havlik RJ, Hayes JTn (2000) Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures. Plast Reconstr Surg 105:1956–1966

    CAS  PubMed  Google Scholar 

  208. McMasters KM, Wong SL, Edwards MJ, Chao C, Ross MI, Noyes RD, Viar V, Cerrito PB, Reintgen DS (2002) Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 9:137–141

    Article  PubMed  Google Scholar 

  209. Starz H, Balda BR, Kramer KU, Buchels H, Wang H (2001) A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 91:2110–2121

    Article  CAS  PubMed  Google Scholar 

  210. Salti GI, Das Gupta TK (2003) Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases. Am J Surg 186:98–101

    Article  PubMed  Google Scholar 

  211. McMasters KM, Reintgen DS, Ross MI, Gershenwald JE, Edwards MJ, Sober A, Fenske N, Glass F, Balch CM, Coit DG (2001) Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 19:2851–2855

    CAS  PubMed  Google Scholar 

  212. Lens MB, Dawes M, Newton-Bishop JA, Goodacre T (2002) Management of regional lymph nodes in patients with malignant melanoma: questionnaire survey of UK current practice. Br J Plast Surg 55:372–375

    Article  CAS  PubMed  Google Scholar 

  213. Edge SB, Niland JC, Bookman MA, Theriault RL, Ottesen R, Lepisto E, Weeks JC (2003) Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst 95:1514–1521

    Article  PubMed  Google Scholar 

  214. Lucci A Jr, Kelemen PR, Miller Cr, Chardkoff, L, Wilson L (2001) National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 192:453–458

    Article  PubMed  Google Scholar 

  215. Shoher A Lucci A (2003) Emerging patterns of practice in the implementation and application of sentinel lymph node biopsy in breast cancer patients in the United States. J Surg Oncol 83:65–67

    Article  PubMed  Google Scholar 

  216. Porter GA, McMulkin H, Lovrics PJ (2003) Sentinel lymph node biopsy in breast cancer: Canadian practice patterns. Ann Surg Oncol 10:255–260

    Article  PubMed  Google Scholar 

  217. Kühn T, Bembenek A, Büchels H, Decker T, Dunst J, Müllerleile U, Munz DL, Ostertag H, Sautter-Bihl ML, Schirrmeister H, Tulusan AH, Untch M, Winzer KJ, Wittekind C (2003) Sentinel-Node-Biopsie beim Mammakarzinom. Geburtsh Frauenheilk 63:835–840

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Chirurgie und Klinische Onkologie, Charité, Campus Buch, Robert-Rössle-Klinik im HELIOS Klinikum Berlin, Lindenberger Weg 80, 13125, Berlin, Germany

    T. Schulze, A. Bembenek & P. M. Schlag

Authors
  1. T. Schulze
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Bembenek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. M. Schlag
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. M. Schlag.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schulze, T., Bembenek, A. & Schlag, P.M. Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbecks Arch Surg 389, 532–550 (2004). https://doi.org/10.1007/s00423-004-0484-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-004-0484-9

Keywords

Search

Navigation